Status:
COMPLETED
Efficiency And Quality In Post-Surgical Pain Therapy After Discharge
Lead Sponsor:
University of Nebraska
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Opioid Use
Opioid Dependence
Eligibility:
All Genders
19-89 years
Phase:
NA
Brief Summary
Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The ...
Detailed Description
Prior to discharge from the hospital, patients will be approached regarding interest in the study with an introductory letter that describes the content and purpose of the study. Following informed co...
Eligibility Criteria
Inclusion
- 19-89 years old
- Access to a smartphone (iOS or Android)
- Inpatient surgery requiring at least over-night hospitalization and anticipated discharge to home
Exclusion
- Re-hospitalization within 30 days
- Pregnant
- Unable to read the English language
- Discharge to a post-acute care facility
- Contraindications to opioids, acetaminophen, or NSAIDs
- Long-term opioid therapy (AHRQ definition - opioid use on most days \>3 months) prior to surgery
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2023
Estimated Enrollment :
711 Patients enrolled
Trial Details
Trial ID
NCT05221866
Start Date
May 2 2022
End Date
December 10 2023
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198